MEGAN SCOTT: Open Payments
NPI 1033453634 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$235 in 9 payments from 6 companies in 2025. Trend: 2023 $195 · 2024 $23 · 2025 $235
Food & beverage: $235
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 3 | $59 |
| Janssen Biotech, Inc. | 2 | $50 |
| Organogenesis Inc. | 1 | $41 |
| Astellas Pharma US Inc | 1 | $37 |
| BeiGene USA, Inc. | 1 | $28 |
| Smith+Nephew, Inc. | 1 | $20 |
Products named: Ozempic, APLIGRAF, Veozah, RYBREVANT, TEVIMBRA, ERLEADA, RENASYS TOUCH.
Industry payments across NY — which companies pay providers there.
